Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H30NO3S.Br |
Molecular Weight | 420.405 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCC1)C2=CC=CS2
InChI
InChIKey=VWGJUXTWIWCQGL-UHFFFAOYSA-M
InChI=1S/C18H30NO3S.BrH/c1-4-19(3,5-2)12-13-22-17(20)18(21,15-9-6-7-10-15)16-11-8-14-23-16;/h8,11,14-15,21H,4-7,9-10,12-13H2,1-3H3;1H/q+1;/p-1
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
5 mg 3 times / day multiple, oral Dose: 5 mg, 3 times / day Route: oral Route: multiple Dose: 5 mg, 3 times / day Sources: |
unhealthy, 63.5 years (range: 36-85 years) n = 20 Health Status: unhealthy Age Group: 63.5 years (range: 36-85 years) Sex: M+F Population Size: 20 Sources: |
Disc. AE: Swallowing difficult... AEs leading to discontinuation/dose reduction: Swallowing difficult (1 patient) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Swallowing difficult | 1 patient Disc. AE |
5 mg 3 times / day multiple, oral Dose: 5 mg, 3 times / day Route: oral Route: multiple Dose: 5 mg, 3 times / day Sources: |
unhealthy, 63.5 years (range: 36-85 years) n = 20 Health Status: unhealthy Age Group: 63.5 years (range: 36-85 years) Sex: M+F Population Size: 20 Sources: |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m873
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2110700
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
100000079758
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
MA4DVZ926O
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
SUB14798MIG
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
C102258
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
200-478-2
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
6066
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
60-44-6
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
DTXSID60875110
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY | |||
|
61814
Created by
admin on Fri Dec 15 16:30:19 GMT 2023 , Edited by admin on Fri Dec 15 16:30:19 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD